Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01)
The summary for the Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01): Use of “trained observers” for clinical evaluation of transdermal irritation has the potential for observer bias and variability in assessment since the various transdermal systems that are applied on subjects for such studies are usually visually dissimilar. Use of digital images and image analysis software/s has the potential to enhance consistency and reliability of the measurements compared to visual assessment. The purpose of this study is to help evaluate if digital imaging can be used to quantify transdermal irritation and for non-inferiority analysis of generic transdermal systems.
|Federal Grant Title:||Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01)|
|Federal Agency Name:||Food and Drug Administration|
|Grant Categories:||Consumer Protection Food and Nutrition Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-FD-16-010|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Food and Drug Administration_Research|
|Current Application Deadline:||May 31, 2016|
|Original Application Deadline:||May 31, 2016|
|Posted Date:||Apr 1, 2016|
|Creation Date:||Apr 1, 2016|
|Archive Date:||Jun 30, 2016|
|Total Program Funding:||$250,000|
|Maximum Federal Grant Award:||$250,000|
|Minimum Federal Grant Award:||none|
|Expected Number of Awards:||1|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
City or township governments
Special district governments
Native American tribal governments (Federally recognized)
- Additional Information on Eligibility
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- Full Announcement of RFA-FD-16-010
- Grant Announcement Contact
- Eric Bozoian
Grants Management Specialist
Food and Drug Administration 240-402-7592
- More Grants from the Food and Drug Administration
- • FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
- • Drug Development Tools Research Grants (U01 Clinical Trial Not Allowed)
- • Rare Disease Clinical Outcome Assessment Consortium (U01 Clinical Trial Not Allowed)
- • Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
- • Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Imple...